Imaging Diagnostic Systems Inc announced that the U.S. Patent application submitted by Robert H. Wake/ VP of Engineering and Richard J. Grable entitled: "Medical optical imaging scanner using multiple wavelength simultaneous data acquistion for breast imaging", was awarded by the United States Patent and Trademark Office and assigned to Imaging Diagnostic Systems (IDSI) as U.S. Patent No. 6,571,116.

This patent, IDSI's twelfth, discloses simultaneous acquisition of several wavelengths of light during an optical computed tomography scan. The practical use for this technology will be to simultaneously acquire an absorption image and a fluorescence image. IDSI has previously patented fluorescence imaging with U.S. Pat. No. 5,952,664, issued on Sep. 14, 1999. This new patent extends its usefulness.

Imaging Diagnostic Systems has received CE Marking, UL listing, ISO 9002 certification and FDA export certification for its CTLM system. Under the new Modular submission approach, the Company's PMA application has been divided into different modules, each of which contained specific information required for the FDA review process. The FDA has accepted the first four modules. The CTLM system is the first patented breast-imaging system that utilizes state of the art laser technology and patented algorithms to create 3-D cross sectional images of the breast. The CTLM system is a non-invasive, painless examination that does not expose the patient to radiation nor require breast compression.